Opinion|Videos|October 14, 2024
Dravet Syndrome and Caregiver Burdens
Author(s)M. Scott Perry, MD
Key Takeaways
- Caregivers manage frequent, severe seizures and complex treatment regimens, impacting their emotional and psychological well-being.
- Accessing appropriate healthcare resources and support systems poses significant challenges for caregivers.
Scott Perry, MD, discusses how caregivers of patients with Dravet syndrome face significant challenges and emphasizes the importance of health care providers navigating sensitive conversations with empathy, clear communication, and comprehensive support to address caregivers’ concerns and needs.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the challenges associated with caregivers of patients with Dravet syndrome?
- How do you navigate challenging conversations with caregivers?
Advertisement
Related to this article
The FDA lifted a clinical hold on simufilam, clearing Filana Therapeutics, formerly Cassava Sciences, to begin a phase 2a study in TSC-related epilepsy.
Xenon Pharmaceuticals submitted an FDA new drug application for azetukalner, a KV7 potassium channel opener, as adjunctive therapy for focal seizures in epilepsy.
Here's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 18, 2026.
Marketed as Fayuvi, the 1-time AAV9 gene therapy showed sustained cerebrospinal fluid heparan sulfate drops and developmental gains among pediatric patients with mucopolysaccharidosis type IIIA in prior studies.
Amy Waldman, MD, Medical Director of the Leukodystrophy Center at Children's Hospital of Philadelphia, discusses zilganersen's mechanism, safety profile, clinical considerations, and what the first-ever approval for Alexander disease means for the broader leukodystrophy field.
In recognition of International Ataxia Awareness Day, observed annually on September 25, NeurologyLive® reviews 6 investigational agents in clinical development across ataxia-related disorders.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 25, 2026.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
SKY-0515 Shows Sustained Benefit at 15 Months in Huntington Disease
2
Ulefnersen Meets Primary End Point in Phase 3 FUSION Trial for FUS-ALS
3
Closing the Gaps in Cluster Headache Care: Jennifer Fokas, MD; Minali Nigam, MD
4
From Biomarkers to Prevention: Key Alzheimer Research Stories of 2026
5